Ipsen finalise l’acquisition de tous les actifs d’OBI-1 d’Octagen Corporation

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021